Current status of research on the relationship between metformin and gynecological tumor / 中国医师进修杂志

ABSTRACT

Metformin, a representative of biguanides, is currently the world's first line of treatment for type 2 diabetes. A considerable number of studies have showed that it can inhibit the occurrence and development of liver cancer, pancreatic cancer, breast cancer and other malignant tumors. In the field of gynecology, over the years, with the early detection rate of gynecological tumors and the improvement of surgical methods, the research on the prognosis and control of gynecological tumor has become a hot research topic in clinical and scientific research, and has been related to the research on the relationship between metformin and gynecological tumor. This shows that metformin in the field of gynecological cancer has a very optimistic prospects and research space. In this review, we will discuss the recent progress in the study of metformin in the field of gynecologic oncology.